Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
The American Review of Respiratory Disease|April 1, 1993
Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apneaN B Kribbs, A I Pack, L R Kline, et al.
Investigational New Drugs|February 1, 1991
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinomaS R Patel, L K Kvols, J Rubin, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphismY Liu, H Jeong, H Takahashi, et al.
International Journal of Obesity (2005)|January 25, 2014
The association between sleep patterns and obesity in older adultsS R Patel, A L Hayes, T Blackwell, et al.
Investigational New Drugs|September 18, 1998
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomasS R Patel, M A Burgess, N E Papadopolous, et al.
Sleep|March 11, 1998
The Sleep Heart Health Study: design, rationale, and methodsS F Quan, B V Howard, C Iber, et al.
Sleep|January 7, 1998
An instrument to measure functional status outcomes for disorders of excessive sleepinessT E Weaver, A M Laizner, L K Evans, et al.
Arthritis and Rheumatism|April 13, 2004
The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritisK E Hansen, J Cush, A Singhal, et al.
Blood|April 15, 1994
An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow culturesG Brunner, C N Metz, H Nguyen, et al.
Clinical Pharmacology and Therapeutics|January 29, 2011
The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African AmericansM A Perera, E Gamazon, L H Cavallari, et al.
Pageof 22